Determinan Quality of life Pada Pasien TB Paru di Kota Surabaya


  • Eppy Setiyowati Universitas Nahdlatul Ulama Surabaya
  • Umi Hanik unusa
  • Diba Adiba Universitas Nahdlatul Ulama Surabaya
  • Elok Mazida Mazida
  • Ratna Sri Wahyuni
  • Feri Agus Andriawan
  • Siti Hardianti




Quality of life, pulmonary tuberculosis, the bacterium mycobacterium, health care, life expectancy


Tuberkulosis (TB) is an infectious disease caused by Mycobacterium tuberculosis, which can attack various organs, especially the lungs. The infectius disease untreated or treatment is not complete can causing complications dangerous until death. TB estimated to have existed in the world since 5000 BC, but advances in the discovery and control of new TB disease occurred in 2 of the last century. This study aimed determinant of quality of life in patients with pulmonary TB in Surabaya

Type a descriptive research with survey approach on three large health centers with a total population sample of 150 respondents. The variable determinant of quality of life includes the respondents perception of the disease, health care search is done, the meaning of life for the respondents, satisfaction with family and health care. Data were collected through questionnaires, through purpusive sampling techniques, then performed the frequency distribution and crostabulasi.

The results showed that the respondents' perceptions of the disease is mostly 78.4% said the illness as a result of the process of transmission of TB bacteria mycobaterium, the search for health services 95.7% went to the clinic, the meaning of life for themselves 78.6% said there was no hope for healed, satisfaction with family 67.5% are satisfied with the spirit given by family members and satisfaction of health workers say 85.3% are satisfied with the services provided by a health worker.

The conclusion shows that detrminan quality of life in patients with pulmonary tuberculosis have searched for health services to the health service, satisfied with the health workers, but there is no hope of life to recover. Suggestions for further research to dig deeper into the life expectancy of the respondents


Download data is not yet available.


Adeyeye, O.O., Ogunleye, O.O., Coker, A., Kuylnu, Y., Bamisile, R.T., Ekrikpo, U., & Onadeko, B. (2014). Factors influencing quality of life and predictors of low quality of life scores in patients on treatment for pulmonary tuberculosis: a cross sectional study. Journal of Public Health in Africa vol 5:366, 88-92.
Ahmad, N., Javaid, A., Sulaiman, S.A.S., Basit, A., Afridi, , A.K., Jaber, A.A.S., & Khan, A.H. (2016). Effect of Multidrug Resistant Tuberculosis Treatment on Patients’ Health Related Quality of Life: Results from a Follow Up Study. Plos One11 (7), 1-16.
Akhsata, J.S., Anushree, C. (2016). Management of multidrug resistanr tuberculosis (MDR-TB)-Monitoring is the key to successful outcome. Egyptian Journal of Chest Disease and Ruberculosis vol 65 issue 2, 447-450.
Alene, K.A., Clements, A.C.A., McBryde, E.S., Jaramillo, E., Lonroth, K., Shaweno, D., Gulliver, A., & Viney, K. (2018). Mental health disorders, social stressors, amd health-related quality of life in patients with multidrug-resistant tuberculosis: A systematic review and meta-analysis. Journal of Infection vol 77 issue 5, 357-367.
Al-Qahtani, M.F., El-Mahalli, A.A, Al-Dossary, N., Muhaish, A.A, Otaibi, S.A., & Baker, F.A. (2014). Health-related quality of life of tuberculosis patients in the Eastern Province, Saudi Arabia. Journal of Taibah University Medical Science 9(4), 311-317
Asgedom, S.W., Teweldemedhin, M., Gebreyesus, H. (2018). Prevalence of Multidrug-Resistant Tuberculosis and Associated Factors in Ethiopia: A Ayatematic Review. Journal of Pathogens, 1-8. Diakses pada 5 November 2018 jam 13.55 WIB dari .
Brown, J., Capocci, S., Smith, C., Morris, S., Abubakar, I., Lipman, M. (2015). Helath status and quality of life in tuberculosis. International Journal of Infectious Disease 32, 68-75.
Dawar, U., Garg, A., Oswal, R., & Patel, K.R. (2016). A study of prevalence of depression in patients multi drug resistant tuberculosis. European Respiratory Journal (48). Diakses dari pada 1 November 2018 jam 12.10 WIB
Farias, S.N.P, Medeiros, C.R.S, Paz, E.P.A, Lobo, A.J.S.L, & Ghelman, L.G. (2013). Completeness in caring: Study of Quality of Life in Clients with Tuberculosis. Esc Anna Nery 17(4), 749-754.
Falzon, D., Mirzayev, F., Wares, F., Baena, I.G., Zignol, M., Linh, N., Weyer, K., Jaramillo, E., Floyd, K., & Riviglione, M. (2015). Multidrug-resistant tuberculosis aropund the world: what progress has been made?. Eur Respir J; 45, 150-160.
Hays, R.D. & Morales, L.S. (2001). The RAND-36 measure of health-related quality of life. Ann Med, 33, 350-357.
He, X., Zang, X., Zhao, J., Liu, Y., Yu, C., Yang, G., Li, H. (2016). Epidemiological Trends of Drug Resistanr Tuberculosis in China from 2007 to 2014: A Retrospective Study. Medicine vol 95 issue 15, 1-7.
Kakhki, A.D. & Masjedi, M.R. (2015). Factors Associated with Health-Related Quality of Life in Tuberculosis Patients Referred to the National Institute of Tuberculosis and Lung Disease in Tehran. Tuberculosis and Respiratory Disease, 78, 309-314.
Kendall, E.A., Azman, A.S., Cobelens, F.G., & Dowdy, D.W. (2017). MDR-TB treatment as prevention: The projected population level impact of expanded treatment for multidrug-resistant tuberculosis. Plos One 12(3), 1-16. Diakses dari pada 5 November 2018 jam 14.07 WIB.
Onyedum, C.C., Alobu, I., & Ukwaja, K.N. (2017). Prevalence of drug-reistant tuberculosis in Nigeria: A systematic review and meta-analysis. Plos One 12(7), 1-17. Diakses dari pada 5 November 2018 jam 14.02 WIB.
Peddireddy, V. (2016). Quality of Life, Psychological Interventions and Treatment Outcome in Tuberculosis Patients: The Indian Scenario. Frontiers in Psychology,vol 7(1664), 1-9.
Prakash, B., Sahu, D., Khare, P., & Bhatnagar, A.K. (2016). Multidrug resistant tuberculosis: Understanding the past for the better future. Int. Med. Public Health vol 6 issue 1, 45-49.
Rajkumar, L. C. (2015). Quality of Life of Multi Drug Resistant Tuberculosis Patients in India. International Multidisciplinary Research Journal vol 5 issue 2, 1-8.
Sharma, R., Yadav, R., Sharma, M., Saini, V., & Koushal, V. (2013). Quality of Life of Multidrug Resistant Tuberculosis Patients: a Study of North India. Acta Medica Iranica; 52(6), 448-453.
Udwadia, Z.F., & Moharil, G. (2016). Multidrug-resistant-tuderculosis treatment in the Indoan private sector: Result from a tertiary referral private hospital in Mumbai. Lung Indoa vol 31 issue 4, 336-341.
Warkicho, A., Kassahun, W., & Alemseged, F. (2017). Risk factors for multidrug-resistant tuberculosis among tuberculosis patients: a case-control study. Dovepress: 10, 91-96.
WHO. (2018). WHOQOOL: Measuring Quality of Life. World Health Organization. Diakses dari pada 30 Oktober 2018 jam 13.45 WIB.




How to Cite

Setiyowati, E., Hanik, U. ., Adiba, D., Mazida, E. M., Sri Wahyuni, R. ., Agus Andriawan, F. ., & Hardianti, S. . (2020). Determinan Quality of life Pada Pasien TB Paru di Kota Surabaya. Journal of Health Sciences, 13(2), 116–123.